Khloris Biosciences, Inc. — Form D

Khloris Biosciences, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-11. $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2018-12-11
• Form: D
• Accession: 0001760227-18-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Amount sold: $5.0M
• Minimum investment: $100K
• Investors: 1
• Date of first sale: 2018-12-06
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-327596

Issuer

• Name: Khloris Biosciences, Inc.
• CIK: 0001760227
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 329 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
• Phone: 415-937-1459

Officers, directors & promoters (3)

More

• CIK 1760227 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search